RxDoctor Payments Data

Maria Kasper

Foot & Ankle Surgery · York, PANPI 1164486247

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.5% of the total across 171 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Organogenesis Inc. at 41.5% of the total.

$4,190in general payments, 2019–2025

Across 171 payments — averaging $24.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$2K
  • Treace Medical Concepts, Inc.$637
  • Smith+Nephew$339
  • Stryker$292
  • Averitas Pharma Inc.$243
  • Ortho Dermatologics, A Division Of Bausch Health US, LLC$173
  • plus $768 from 16 others
$195,542in research payments, 2019–2025

Across 37 payments — averaging $5284.92 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Endo Pharmaceuticals Inc.$106K
  • Integra Lifesciences Corporation$64K
  • Globus Medical$26K

What the payments were for

  • Travel & lodging$1474%
  • Food & beverage$4,04396%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,190 in reported general payments places this provider in the 60th percentile of 575 foot & ankle surgery providers in Pennsylvania.

See all foot & ankle surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$269,334
Medicare patients
420
Services billed
10,143

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Econazole Nitrate21$768
Doxycycline Monohydrate27$501
Ciclopirox11$379
Gabapentin32$362
Doxycycline Hyclate20$334
Cephalexin37$219
Methylprednisolone17$106

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in York

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →